|
HS Code |
585439 |
| Product Name | Rhamnosylvitexin |
| Chemical Formula | C27H30O14 |
| Molecular Weight | 578.52 g/mol |
| Iupac Name | 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(6-O-α-L-rhamnosyl)-β-D-glucopyranosyloxy]-4H-chromen-4-one |
| Cas Number | 3681-93-4 |
| Appearance | Yellow powder |
| Solubility In Water | Slightly soluble |
| Melting Point | Approx. 230°C (decomposes) |
| Purity | ≥98% (HPLC) |
| Storage Conditions | Store at -20°C, protected from light |
| Source | Naturally found in plants such as hawthorn |
As an accredited Rhamnosylvitexin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Rhamnosylvitexin is packaged in a 100 mg amber glass vial, sealed and labeled with chemical name, purity, and batch number. |
| Shipping | Rhamnosylvitexin is shipped in secure, airtight containers to prevent contamination and degradation. It is protected from light, moisture, and extreme temperatures throughout transit. Appropriate chemical labeling and documentation are provided, ensuring compliance with safety regulations for domestic and international delivery of laboratory chemicals. Expedited and temperature-controlled shipping options are available if required. |
| Storage | Rhamnosylvitexin should be stored in a tightly sealed container, protected from light and moisture, at a temperature of 2-8°C (refrigerator conditions). To maintain stability, avoid exposure to heat and direct sunlight. Handle under dry and clean conditions, ensuring the storage area is free from incompatible materials, such as strong acids or oxidizers. Proper labeling is recommended for identification and safety. |
|
Purity 98%: Rhamnosylvitexin with purity 98% is used in pharmaceutical formulation development, where it ensures high bioavailability and consistent therapeutic outcomes. Molecular Weight 594.52 g/mol: Rhamnosylvitexin at molecular weight 594.52 g/mol is applied in metabolic pathway research, where reliable compound identification is achieved. Particle Size <10 µm: Rhamnosylvitexin with particle size below 10 µm is used in topical dermatological applications, where enhanced percutaneous absorption is obtained. Stability Temperature up to 60°C: Rhamnosylvitexin stable up to 60°C is employed in nutraceutical manufacturing, where thermal stability maintains ingredient integrity during processing. HPLC Assay ≥99%: Rhamnosylvitexin with HPLC assay of at least 99% is used in analytical reference standards, where precise quantification and reproducibility are facilitated. Solubility in Ethanol 25 mg/mL: Rhamnosylvitexin exhibiting solubility in ethanol at 25 mg/mL is used in botanical extract standardization, where homogeneous formulation is achieved. Melting Point 260–265°C: Rhamnosylvitexin with melting point range 260–265°C is used in solid dosage form development, where material stability during processing is ensured. Shelf Life 24 Months: Rhamnosylvitexin with a shelf life of 24 months is used in long-term storage applications, where extended product usability is supported. UV Absorption Maximum 350 nm: Rhamnosylvitexin with UV absorption maximum at 350 nm is applied in photoprotective cosmetic products, where efficient UV filtration is delivered. Water Content ≤2%: Rhamnosylvitexin with water content not exceeding 2% is used in lyophilized powder preparations, where reduced hygroscopicity improves product longevity. |
Competitive Rhamnosylvitexin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of natural active molecules, Rhamnosylvitexin stands out for both its complexity and the practical results it brings to research and industry. For years, our plant chemistry team has focused on producing high-purity Rhamnosylvitexin because its unique structure and bioactivity have opened doors for a surprising range of projects, especially in pharmaceuticals, cosmetics, and functional foods. Working through the challenges of extraction, purification, and scale-up taught us that not all natural glycosides are created equal. Even batches grown in the same region show measurable differences in their profiles; so attention to detail in every step from raw material sourcing to final packaging has been critical for us.
Taking Rhamnosylvitexin from a lab curiosity to a reproducible industrial ingredient was an uphill journey. Our team invested heavily in chromatography facilities, not just to reach impressive purity numbers on paper, but to deliver consistent molecular profiles from order to order. Customers involved in pharmacological assays and formulation needed material that performed the same each time. High-performance liquid chromatography and mass spectrometry runs back up every lot. Anyone in the field knows that a slightly off-spec plant extract can derail both preclinical testing and manufacturing campaigns. The model we routinely produce targets a purity level above 98%—we manually cross-reference the HPLC chromatograms before each shipment—and the underlying polysaccharide fingerprint remains constant.
Over the past decade, researchers and formulators have used our Rhamnosylvitexin for different ends. Early on, most of our customers came from academic or pharmaceutical backgrounds, drawn by literature supporting antioxidant or anti-inflammatory properties. Clinical formulation teams want to know the molecule will remain stable and function under various conditions. To meet that, we developed a standard powder form, free-flowing and amenable to reconstitution or blending. In cosmetics manufacturing, ingredient compatibility is essential, so we test Rhamnosylvitexin’s solubility in both polar and non-polar solvents. Recent collaborations focused on its UV-protective and soothing effects for skin, which demanded even closer monitoring of trace contaminants and water content. As more research emerges, customers increasingly expect clear data on residual solvents, heavy metals, and microbial counts—so we make sure those parameters meet international standards before anything leaves our facility.
The world of flavonoids is crowded, but Rhamnosylvitexin distinguishes itself both structurally and functionally. Compared with apigenin glycosides or vitexin alone, we noticed Rhamnosylvitexin resists degradation in acidic matrices more reliably. Colleagues developing oral health applications point out improved bioavailability in this form—an advantage that sits well with both supplement and medical device makers. Some ask about the difference versus simply using pure vitexin. We explain that the rhamnose sugar added during biosynthesis alters both polarity and cellular uptake, and our process preserves that subtlety. Other manufacturers may opt for quick or partial extraction, sometimes sacrificing minor components, but our years in process optimization convinced us that full-spectrum yield is more valuable, especially to researchers conducting mechanistic studies.
Years of shipping to global customers highlighted an under-appreciated truth: paperwork and certificates are not enough by themselves. Scientists and buyers across continents rightfully ask for more—detailed batch records, confirmed analytical spectra, and confirmation of constant quality beyond the basic certificate of analysis. After one client’s clinical trial was delayed due to material variance from a previous supplier, our policy became simple: make every analytical report available for review upon request, and method validation data too. Repeat orders from pharmacology groups tell us this policy pays off. Quality isn’t a slogan; it’s routine, confirmed by third-party re-testing, especially when requested by top-tier pharmaceutical and cosmetic enterprises.
Rhamnosylvitexin starts with agricultural partnerships developed over seasons, not months. To obtain the best yield of the targeted molecule, our team consults directly with farmers on planting times, irrigation spacing, and disease management. Poor harvest years test our forecasting models more than anything else, so holding buffer stocks of selected plant material is non-negotiable for us. Extraction yields naturally fluctuate with growing conditions, but ongoing dialogue with our suppliers helps keep things on track. One year, after a region-wide drought dropped yields by a quarter, we committed to pre-contracts and field visits, giving our suppliers security and ourselves a steadier stream of raw material. Some competitors may choose short-term cost savings; we see value in long-term relationships, better for both sides.
Quality for Rhamnosylvitexin hinges not just on extraction, but on critical steps that follow. Early experiments showed us the pitfalls of solvent temperature drift, so our reactors are monitored with digital controls and maintained to tight tolerances. Chromatographic separation forms the backbone of our process. We tune flow rates and run sequential fractions to increase the main peak and reduce side products, so even as plant input varies, our output remains steady. Filtration and drying stages are no less important. Traditional air-drying techniques often allow air-borne contaminants, so we use closed-system vacuum dryers and check for both chemical and microbial stability post-drying. This hands-on oversight, combined with our batch record system, gives users confidence in the reproducibility of our output.
Anyone who has worked in natural extracts knows that plant chemicals sometimes come with unexpected secondary components. Over the years, our internal testing teams uncovered trace alkaloids and other naturally occurring substances that can slip through basic extraction methods. Each new harvesting season, we adjust our screening methods to catch trace-level molecules that might interact with Rhamnosylvitexin in sensitive downstream applications. Cosmetic formulators in particular ask about allergens and heavy metals—so periodic audits and redundant cross-checks keep our product profile clean and predictable. Case in point, our microbiology laboratory started environmental monitoring well before it was an industry standard, based on early findings from product stability studies.
Customer feedback shapes our development priorities. After pharmacological partners pointed out issues with product clumping under high-humidity shipping conditions, we reworked our drying process and packaging to include desiccants in every shipment. This cut down on caking, kept powder flow properties, and saved time for end-users prepping formulations. Recent requests from supplement companies spurred us to include detailed allergen and gluten testing, which meant more lab hours for our QC team—but led to more repeat business as well. Academic labs running animal studies care just as much about batch-to-batch consistency as multinational corporations. Our team shares full analytical data when requested and can supply reference standards to researchers for calibration purposes. Regular conversations with formulators and bench scientists guide our upgrades—whether switching to greener solvents, or improving residue removal steps.
Getting high-purity Rhamnosylvitexin to the end user intact requires more than drop-in-the-box packaging. Our choice of container comes from experience; high-barrier aluminum-laminated bags inside rigid drums stave off both moisture and light-induced degradation. Over several shipping cycles, we monitored temperature and humidity inside packages and made adjustments: adding a secondary inner seal, introducing vacuum packing for larger orders, and placing extra desiccant packs for long-haul or cross-climate logistics. These changes look minor from the outside, but one frozen December shipment highlighted the difference—customer testing showed full retention of assay values on arrival, even after customs delays. Tight tracking of our distribution chain reduces both formal complaints and informal headaches for the end user.
Joint projects with universities and industrial labs keep us alert to new uses and changing spec requirements for Rhamnosylvitexin. One project focused on enhancing water solubility for beverage applications, leading us to refine our micronization process. In another, dermatologists needed the molecule’s photoprotective qualities sustained after blending with standard sunscreens, requiring us to validate compatibility under various light and pH conditions. Our role in these projects goes beyond supplier; sometimes, we tweak batch protocols or run side-by-side analytics with customer labs. These lessons feed back into our standard offerings, making our Rhamnosylvitexin a better fit for a range of projects, from pilot trials to commercial launches.
Chemical manufacturing always carries risk, but we take deliberate steps to reduce it for our customers. Every Rhamnosylvitexin batch we produce has a full traceability path: from plant lot, through every analytical checkpoint, to shipping docket. This lets scientists, QA managers, or purchasing teams answer any regulatory or experimental query quickly, without chasing third-party bottlenecks. In fields where recalls or regulatory flags can set projects back by months, that speed matters. Our policy of keeping back-up reference samples for at least three years after production ensures we can address any follow-up concerns. Security isn’t just locked doors on a plant; it’s secure processes and personal accountability.
Over decades, we’ve learned where to channel investments for the most impact. Robust instrumentation—HPLC, MS, NMR—only go so far without the expertise to interpret and refine manufacturing steps. Our plant chemists, QC specialists, and logistics staff all cross-train to spot potential problems before they scale up. During an equipment failure that briefly impacted drying uniformity, it was one of our junior technicians who flagged a measurement drift and pulled the batch for extra scrutiny. Training, redundant checks, and weekly debriefs catch most issues, long before external audits or customer feedback make them urgent.
Working as an actual manufacturer means living with both the science and the responsibility. Our experience with Rhamnosylvitexin goes beyond generalized data sheets; we’ve solved real manufacturing problems, handled large customer orders, and partnered with R&D clients during unexpected interruptions. This knowledge means we’re ready to speak in detail about structure-activity relationships, best-use-case scenarios, and the inevitable curveballs that come with novel research or fast-evolving regulations. Anyone can claim high standards—our repeat business and near-zero non-conformity rate show that we live those standards daily. The trust gained from getting batches right, time after time, pays off not just for us, but for every company or lab that relies on our molecules.
As researchers continue to uncover new uses for Rhamnosylvitexin, we’re committed to responding with high-quality material, direct support, and a mindset of continual learning. Not every season brings record harvests. Regulations will continue to evolve. Formats and applications will diversify. As the original manufacturer, we stand behind our product at every stage—from field, to lab, to your facility. If Rhamnosylvitexin is the right fit for your project, so is our experience and commitment to your supply chain’s success.